(19)
(11) EP 4 101 478 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
08.01.2025 Bulletin 2025/02

(45) Mention of the grant of the patent:
04.12.2024 Bulletin 2024/49

(21) Application number: 22188042.0

(22) Date of filing: 28.10.2016
(51) International Patent Classification (IPC): 
A61L 15/24(2006.01)
A61P 7/04(2006.01)
 A61P 17/02(2006.01)
(52) Cooperative Patent Classification (CPC):
A61L 15/24; A61L 2400/04; A61P 17/02; A61P 7/04
 
C-Sets:
A61L 15/24, C08L 1/00;

(54)

COMPACTED HEMOSTATIC CELLULOSIC AGGREGATES

VERDICHTETE HÄMOSTATISCHE CELLULOSISCHE AGGREGATE

AGRÉGATS CELLULOSIQUES HÉMOSTATIQUES COMPACTÉS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 06.11.2015 US 201562251773 P
08.08.2016 US 201662371954 P
14.10.2016 US 201662408176 P

(43) Date of publication of application:
14.12.2022 Bulletin 2022/50

(60) Divisional application:
24214899.7
24216810.2

(62) Application number of the earlier application in accordance with Art. 76 EPC:
16805555.6 / 3370783

(73) Proprietor: Cilag GmbH International
6300 Zug (CH)

(72) Inventor:
  • WANG, Yi-Lan
    Somerville, 08876 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
US-A- 4 621 011
 US-A1- 2013 316 974
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).